Glatiramer acetate April 12, 2017 Glatiramer acetate Trade Name Copaxone Orphan Indication Multiple sclerosis USA Market Approval USA USA Designation Date 1987-11-09 00:00:00 Sponsor Teva Pharmaceuticals USA;1510 Delp Drive;Kulpsville, Pennsylvania, 19443
